Healthtell
China's iCarbonX Invests in SomaLogic, Grows Medical Data Alliance
The bioinformatics startup has also invested in six other companies, committing $400 million to its data-sharing collaboration.
The firm has not disclosed the specific disease the test will address but has determined this space represents the best opportunity for its array technology.
HealthTell Completes $26M Series B Financing Round
The company, which also raised $14 million in a Series A round, plans to use the proceeds to commercialize panels of tests for autoimmune diseases.
ASU Team's Immunosignature Profiles Indicate Technique's Suitability for Longitudinal Testing
Premium
The work found that individuals have steady immunosignatures over time, suggesting longitudinal testing could prove effective for early disease detection.
HealthTell Wins $225K SBIR Grant for Brain Cancer Dx Work
The funds will support work to evaluate the effectiveness of the company's immunosignature technology in the diagnosis of brain cancer.